Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1998-3-6
|
pubmed:abstractText |
The outcome of patients selecting observation of clinical stage T1c prostate cancer is unknown. A total of 101 men with clinical stage T1c prostate cancer were evaluated, counseled, and monitored in a standard fashion. Altogether, 27 men who elected observation were older and had greater co-morbidity but similar tumor characteristics as compared with 74 men who elected radical prostatectomy. In all, 9 men demonstrated clinical or biochemical evidence of progression after a mean follow-up of 23 months; 4 men who underwent radical prostatectomy had specimen-confined disease and undetectable post-operative levels of PSA. Observation appears to be a viable option for some men with clinical stage T1c prostate cancer.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0724-4983
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
15
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
364-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9436286-Aged,
pubmed-meshheading:9436286-Disease Progression,
pubmed-meshheading:9436286-Humans,
pubmed-meshheading:9436286-Male,
pubmed-meshheading:9436286-Middle Aged,
pubmed-meshheading:9436286-Neoplasm Staging,
pubmed-meshheading:9436286-Prostate-Specific Antigen,
pubmed-meshheading:9436286-Prostatectomy,
pubmed-meshheading:9436286-Prostatic Neoplasms,
pubmed-meshheading:9436286-Survival Analysis
|
pubmed:year |
1997
|
pubmed:articleTitle |
Expectant management as an option for men with stage T1c prostate cancer: a preliminary study.
|
pubmed:affiliation |
Department of Surgery, University of North Carolina Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|